Mayinglong Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Mayinglong Pharmaceutical Group has a total shareholder equity of CN¥4.1B and total debt of CN¥164.5M, which brings its debt-to-equity ratio to 4%. Its total assets and total liabilities are CN¥5.1B and CN¥994.3M respectively. Mayinglong Pharmaceutical Group's EBIT is CN¥518.0M making its interest coverage ratio -6.5. It has cash and short-term investments of CN¥3.0B.
Key information
4.0%
Debt to equity ratio
CN¥164.47m
Debt
| Interest coverage ratio | -6.5x |
| Cash | CN¥3.01b |
| Equity | CN¥4.13b |
| Total liabilities | CN¥994.31m |
| Total assets | CN¥5.12b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600993's short term assets (CN¥4.0B) exceed its short term liabilities (CN¥834.8M).
Long Term Liabilities: 600993's short term assets (CN¥4.0B) exceed its long term liabilities (CN¥159.5M).
Debt to Equity History and Analysis
Debt Level: 600993 has more cash than its total debt.
Reducing Debt: 600993's debt to equity ratio has increased from 1.5% to 4% over the past 5 years.
Debt Coverage: 600993's debt is well covered by operating cash flow (513.7%).
Interest Coverage: 600993 earns more interest than it pays, so coverage of interest payments is not a concern.